Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men

PHASE3CompletedINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Osteoporosis
Interventions
DRUG

Zoledronic Acid

Trial Locations (26)

2010

Garvan Institute of Medical Research, Sydney

5041

Repatriation General Hospital, Daw Park

6009

Keogh Institute for Medical Research, Nedlands

10993

Helen Hayes Hospital, West Haverstraw

19610

Radiant Research, Wyomissing

21740

Osteoporosis and Clinical Trials Center, Hagerstown

23249

McGuire VA Medical Center, Richmond

23502

Hampton Roads Center for Clinical Research, Norfolk

30501

United Osteoporosis Center, Gainesville

34996

Radiant Research, Stuart

45219

UC Bone Health and Osteoporosis Center, Cincinnati

50322

Mercy Arthritis and Osteoporosis Center, Des Moines

60611

Northwestern Center for Clinical Research, Chicago

80227

Colorado Center for Bone Research, Lakewood

85704

Catalina Pointe Clinical Research Inc., Tucson

87106

New Mexico Clinical Research and Osteoporosis Center, Albuquerque

94598

Diablo Clinical Research, Walnut Creek

97239

Oregon Health Sciences University, Portland

04401

St. Joseph Hospital, Bangor

V5Z 2N6

Clinical Research Center, Vancouver

B3H 2Y9

QEII HealthSciences Center, Halifax

L8N 1Y2

Charlton Medical Building, Hamilton

H7T 2P5

Centre De Recherche Clinique De Laval, Laval

H3A 1A1

Royal Victoria Hospital, Montreal

G1V 3M7

Groupe de Recherche en Rhumatologie et Maladies Osseuses, Sainte-Foy

S7K 0H6

Saskatoon Osteoporosis Center, Saskatoon

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY